László, K.; Kiss, O.; Vörös, D.; Mintál, K.; Ollmann, T.; Péczely, L.; Kovács, A.; Zagoracz, O.; Kertes, E.; Kállai, V.;
et al. Intraamygdaloid Oxytocin Reduces Anxiety in the Valproate-Induced Autism Rat Model. Biomedicines 2022, 10, 405.
https://doi.org/10.3390/biomedicines10020405
AMA Style
László K, Kiss O, Vörös D, Mintál K, Ollmann T, Péczely L, Kovács A, Zagoracz O, Kertes E, Kállai V,
et al. Intraamygdaloid Oxytocin Reduces Anxiety in the Valproate-Induced Autism Rat Model. Biomedicines. 2022; 10(2):405.
https://doi.org/10.3390/biomedicines10020405
Chicago/Turabian Style
László, Kristóf, Orsolya Kiss, Dávid Vörös, Kitti Mintál, Tamás Ollmann, László Péczely, Anita Kovács, Olga Zagoracz, Erika Kertes, Veronika Kállai,
and et al. 2022. "Intraamygdaloid Oxytocin Reduces Anxiety in the Valproate-Induced Autism Rat Model" Biomedicines 10, no. 2: 405.
https://doi.org/10.3390/biomedicines10020405
APA Style
László, K., Kiss, O., Vörös, D., Mintál, K., Ollmann, T., Péczely, L., Kovács, A., Zagoracz, O., Kertes, E., Kállai, V., László, B., Hormay, E., Berta, B., Tóth, A., Karádi, Z., & Lénárd, L.
(2022). Intraamygdaloid Oxytocin Reduces Anxiety in the Valproate-Induced Autism Rat Model. Biomedicines, 10(2), 405.
https://doi.org/10.3390/biomedicines10020405